Cloud computing, “exhausted” T cells, breast cancer risk in childhood cancer survivors and clinical trial design for CAR-T therapy in solid tumors are among the topics St. Jude Children’s Research Hospital investigators will discuss at the five-day American Association for Cancer Research annual meeting that begins Saturday, April 14, in Chicago.
Secure sharing and collaborative analysis of huge datasets are essential in the quest to discover cures for pediatric cancer. Scott Newman, Ph.D., group lead for bioinformatics analysis in the St. Jude Department of Computational Biology, will present St. Jude Cloud, a new publicly available data-sharing and collaboration platform. His talk is set for 3:05 p.m., Sunday, April 15, in Room N228, Level 2 of McCormick Place North. Abstract: 922
St. Jude Cloud is the world’s largest public repository of pediatric cancer genomics data and also provides unique analysis tools and visualizations. The platform was developed by scientists at St. Jude in collaboration with Microsoft and DNAnexus. St. Jude Cloud allows scientists to explore more than 5,000 whole-genome (WGS), 5,000 whole-exome (WES) and 1,200 RNA-Seq datasets from more than 5,000 pediatric cancer patients and survivors. By 2019, 10,000 whole-genome sequences will be available on St. Jude Cloud.
Along with the presentations detailed below,
Article originally posted at